Euro area vs Senegal: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Euro area
- Senegal
How they compare
Senegal currently reports 21.3% against 7.8% in Euro area, a difference of 13.5%.
That makes Senegal's figure about 2.7 times Euro area's.
Across all 22 years both countries report, Senegal has been ahead every year.
Euro area ranks 47th and Senegal ranks 44th of 47 groups.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Euro area | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.6% | 22.7% | 13.1% | Senegal |
| 2010s | 8.3% | 22.2% | 13.9% | Senegal |
| 2020s | 7.8% | 21.4% | 13.6% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Euro area or Senegal?
- Senegal, at 21.3% against 7.8% in Euro area as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Euro area and Senegal?
- 13.5%, with Senegal ahead.
- How many years of comparable data are there for Euro area and Senegal?
- 22 years are reported by both, from 2000 to 2021.
- How do Euro area and Senegal rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Euro area ranks 47th and Senegal ranks 44th of 47 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).